Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, December 20, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Biotech
Biotech
Biotech
Nimbus Therapeutics Completes Dose Escalation in Phase 1/2 Trial of WRN Inhibitor for MSI-H Tumors
Life Sciences Times
-
December 19, 2025
Biotech
Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform
Life Sciences Times
-
December 17, 2025
Biotech
Valink Therapeutics, Nona Biosciences Form Strategic Biologics Discovery Alliance
Life Sciences Times
-
December 17, 2025
Biotech
nChroma Bio Receives Clinical Trial Authorization to Launch First-in-Human Study of CRMA-1001 for Chronic Hepatitis B
Life Sciences Times
-
December 16, 2025
Biotech
Fondazione Telethon, Orphan Therapeutics Accelerator outline non-profit pathway for U.S. access to ultra-rare gene therapy
Life Sciences Times
-
December 15, 2025
Biotech
Gilead Sciences to Acquire MYR GmbH
Life Sciences Times
-
December 12, 2020
0
Biotech
AstraZeneca to Acquire Alexion
Life Sciences Times
-
December 12, 2020
0
Biotech
Trailblazers: Vertex CEO Reshma Kewalramani on Leadership, STEM, Diversity, Inclusion and Medicine on Chai With Manju
Life Sciences Times
-
December 11, 2020
0
Biotech
Cell Isolation/ Separation Market Worth $15.0 Billion by 2025
Life Sciences Times
-
December 11, 2020
0
Biotech
LifeX Labs, Pittsburgh Life Sciences Greenhouse Teaming up to Fast-track Startups and Innovators
Life Sciences Times
-
December 7, 2020
0
Biotech
Life Sciences Leaders Optimistic About Funding Prospects but Cautious About Growth Outlook, New Research Finds
Life Sciences Times
-
December 7, 2020
0
1
...
75
76
77
Page 77 of 77
Most Read
Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences
December 19, 2025
PureTech Appoints Robert Lyne as Chief Executive Officer
December 19, 2025
Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs
December 19, 2025
Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders
December 19, 2025